These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 10215361)

  • 1. Science commentary: rational drug design for Alzheimer's disease.
    Berger A
    BMJ; 1999 Mar; 318(7184):639. PubMed ID: 10215361
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: Another piece of the Alzheimer's jigsaw.
    Bayer T
    BMJ; 1999 Mar; 318(7184):639. PubMed ID: 10215360
    [No Abstract]   [Full Text] [Related]  

  • 3. Third drug to treat Alzheimer's approved.
    Mayo Clin Health Lett; 2000 Aug; 18(8):4. PubMed ID: 10932951
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivastigmine (Exelon) for Alzheimer's disease.
    Med Lett Drugs Ther; 2000 Oct; 42(1089):93-4. PubMed ID: 11015159
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of rivastigmine in Alzheimer's disease. Patients' view on quality of life should be assessed.
    Selai CE; Trimble MR; Rossor MN; Harvey RJ
    BMJ; 1999 Sep; 319(7210):641-2. PubMed ID: 10523095
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of rivastigmine in Alzheimer's disease. Guidelines do not ignore clinically relevant end points.
    Storosum JG; van Zwieten-Boot BJ; Elferink AJ
    BMJ; 1999 Sep; 319(7210):642. PubMed ID: 10523096
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivastigmine for Alzheimer's disease.
    Drug Ther Bull; 2000 Feb; 38(2):15-6. PubMed ID: 10829350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: new pharmacological perspectives.
    Palacios JM
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():67-8. PubMed ID: 8899698
    [No Abstract]   [Full Text] [Related]  

  • 10. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholinesterase inhibitors in Alzheimer disease: preliminary recommendations for treatment].
    Olde Rikkert MG; Jansen RW
    Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2644; author reply 2645. PubMed ID: 10028367
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of journal advertisements on prescribers of cholinesterase inhibitors.
    Sauer J; Howard R
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):976-8. PubMed ID: 12325061
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alzheimer disease. Pseudo-irreversible AChE inhibition with rivastigmine].
    Med Monatsschr Pharm; 1998 Aug; 21(8):248-9. PubMed ID: 9758554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rivastigmine for Alzheimer disease; evaluation of preliminary results and of structured assessment of efficacy].
    Schölzel-Dorenbos CJ
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):494. PubMed ID: 11913117
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains.
    Erkinjuntti T; Skoog I; Lane R; Andrews C
    Int J Clin Pract; 2003 Nov; 57(9):756-60. PubMed ID: 14686563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acetylcholinesterase inhibitors].
    Rioux S
    Rev Med Suisse Romande; 2003 Jul; 123(7):471-4. PubMed ID: 15088511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA approves new cholinesterase inhibitor for Alzheimer's disease.
    Am J Health Syst Pharm; 2000 Jun; 57(11):1026, 1028. PubMed ID: 10876742
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
    Gasser US; Gasser T
    MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
    [No Abstract]   [Full Text] [Related]  

  • 19. Rivastigmine in the treatment of Alzheimer's disease.
    Deleu D
    Eur Neurol; 2001; 46(2):110. PubMed ID: 11528167
    [No Abstract]   [Full Text] [Related]  

  • 20. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T; Retz-Junginger P; Retz W; Supprian T; Rösler M
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.